RA CAPITAL MANAGEMENT, L.P. sold VOR

October 27, 2025 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. sold 90,941 shares of Vor Biopharma Inc. at $28.12 per share, a transaction worth $2.56M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
90,941
Price
$28.12
Total value
$2.56M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 27, 2025
Filing dateOctober 27, 2025
Shares owned after1,180,060
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.345 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.; RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.; Held directly by the Fund.

View the original Form 4 on SEC EDGAR